DLX5 and acute myeloid leukemia: Furthermore, Cox regression analysis including variables presented in Tables 3 and S4 demonstrated that DLX5 hypermethylation was a negatively prognostic factor independently affecting OS among whole‐chort AML with a trend (P = .071; Table S4) and CN‐AML patients (P = .025; Table 3).